Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Factor VII Shinj o : A Dysfunctional Factor VII Variant Homozygous for the Substitution Gln for Arg at Position 79

View through CrossRef
We report a factor VII (FVII) variant, FVII<sub>Shinjo</sub>, characterized by normal FVII antigen levels and variable procoagulant activity using tissue thromboplastin from different sources. Normal FVII activity is obtained using human placenta thromboplastin but low activity using rabbit or bovine brain thromboplastin. Exons 2-8 and the intron-exon junctions of the FVII genes of the propositus were amplified by PCR from DNA extracted from peripheral white blood cells, and screened by single-strand conformational polymorphism (SSCP) analysis. DNA fragments showing aberrant mobility were cloned and sequenced. We detected a single-point mutation, a homozygous G to A transition at nucleotide position 6,055 in exon 4, which results in the substitution of Arg 79 by Gln in the first EGF-like domain. This mutation results in a loss of a site for the restriction endonuclease Msp I. The Msp I digestion pattern of the PCR-amplified exon 3+4 fragments from each member of the family was determined. The Msp I haplotypes were consistent with this G to A transition being associated with reduced FVII activity as detected using thromboplastins from various species. We conclude that the Arg 79 to Gln substitution in the first EGF-like domain of FVII identified in the propositus is responsible for the inherited FVII abnormality in this Japanese family. We postulate that one of the sites of interaction between FVII and tissue thromboplastin includes Arg 79 in the first EGF-like domain of factor VII.
Title: Factor VII Shinj o : A Dysfunctional Factor VII Variant Homozygous for the Substitution Gln for Arg at Position 79
Description:
We report a factor VII (FVII) variant, FVII<sub>Shinjo</sub>, characterized by normal FVII antigen levels and variable procoagulant activity using tissue thromboplastin from different sources.
Normal FVII activity is obtained using human placenta thromboplastin but low activity using rabbit or bovine brain thromboplastin.
Exons 2-8 and the intron-exon junctions of the FVII genes of the propositus were amplified by PCR from DNA extracted from peripheral white blood cells, and screened by single-strand conformational polymorphism (SSCP) analysis.
DNA fragments showing aberrant mobility were cloned and sequenced.
We detected a single-point mutation, a homozygous G to A transition at nucleotide position 6,055 in exon 4, which results in the substitution of Arg 79 by Gln in the first EGF-like domain.
This mutation results in a loss of a site for the restriction endonuclease Msp I.
The Msp I digestion pattern of the PCR-amplified exon 3+4 fragments from each member of the family was determined.
The Msp I haplotypes were consistent with this G to A transition being associated with reduced FVII activity as detected using thromboplastins from various species.
We conclude that the Arg 79 to Gln substitution in the first EGF-like domain of FVII identified in the propositus is responsible for the inherited FVII abnormality in this Japanese family.
We postulate that one of the sites of interaction between FVII and tissue thromboplastin includes Arg 79 in the first EGF-like domain of factor VII.

Related Results

L-Glutamine Increases IGF-1 Liver Expression to Prevent Bone Loss in Sickle Mice
L-Glutamine Increases IGF-1 Liver Expression to Prevent Bone Loss in Sickle Mice
BACKGROUND: Chronic red blood cell (RBC) hemolysis that accompanies sickle cell disease (SCD) is associated with elevated iron storage in tissues, in particular the liver (Nguyen e...
Influence of Glutamine and Glutamate Supplementation in the Blood Levels of Horses
Influence of Glutamine and Glutamate Supplementation in the Blood Levels of Horses
Background: The most abundant free amino acid in mammals is glutamine (GLN). Little research has focused on GLN supplementation for horses, but GLN levels in this species are known...
Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
Background:The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection associated with coronavirus disease 2019 (COVID-19) causes a 3- to 9-fold higher age-adjusted ...
Glutamine utilization in cancer cells
Glutamine utilization in cancer cells
Metabolic transformation forms the biochemical foundation for oncogenic transformation. In addition to being utilized for protein translation, glutamine (Gln) can serve as carbon a...
The glutamine debate in surgery and critical care
The glutamine debate in surgery and critical care
Purpose of review Glutamine (GLN) is a versatile amino acid, long believed to have important implications in ICU and surgical patients. An extensive body of data examin...
Abstract 1709: Cyanobacteria-derived RNA aptamer supports prostate cancer hormone sensitivity
Abstract 1709: Cyanobacteria-derived RNA aptamer supports prostate cancer hormone sensitivity
Prostate cancer (PCa) hormone therapy resistance is the second leading cause of cancer death among American men. Multiple mechanisms inherent to the disease can lead to castrate-re...
Ecogenetic assessment of the effects of technogenic pollutants on genome stability
Ecogenetic assessment of the effects of technogenic pollutants on genome stability
The aimof the study is to assess the impact of radiation pollution on the stability of the genome and human health, taking into account the long-term genetic consequences.Measureme...
The effect of dietary L-arginine intake on the level of antibody titer, the relative organ weight and colon motility in broilers
The effect of dietary L-arginine intake on the level of antibody titer, the relative organ weight and colon motility in broilers
Abstract This study was carried out to determine the effect of L-arginine (L-Arg) levels in diet at the starter, grower and finisher phases on immune response, organ developme...

Back to Top